- Coordinator
- Beams, France
- Runs
- 1 July 2023 to 31 March 2024
- Status
- Finished
- EU funding
- €75k
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- Coordination and Support Action
- Grant agreement
- 101114157
What the project is doing
In the project's own words, from its summary on CORDIS.
Cancer is the 2nd most common cause of death worldwide. Oncological surgery is the most efficient single-treatment and is the most used as primary treatment. However, the local cancer recurrence rate after the first surgery is still high in every organ. Local cancer recurrence is mainly caused by tumor growth from remaining tumor residues. They have a major impact on survival, quality of life and require reinterventions and/or adjuvant treatments.
Therefore, the main issue today in oncological surgery today is to ensure the resection quality and remove the whole tumor while minimizing healthy tissues removal. To achieve it, surgeons need real time information on tumor residues’ location. Beams is a medtech company, incorporated on the 17th of May 2021 to answer this unmet medical need. Beams develops TRIOP (Tumor Resection IntraOperative Probe) technology, a miniaturized intraoperative probe which measures the accumulation of existing radiotracers in tumor tissues after their injection in the organism, and then informs surgeons in real time about the precise tumor localization to help removing the tumor while preserving surrounding healthy tissues.
The targeted impact is to prevent local cancer recurrence and to preserve patients’ quality of life. The first Beams’ product based on TRIOP technology will be a multi-purpose intelligent surgical aspirator: the detection system will be built around an aspiration tool, to remove tumor cells, blood and other secretions that could alter the detection simultaneously with examining the operative cavity.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Beams | Paris | France | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI